PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
2026-03-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
2026-03-12T    Biotechnology   Computer/Electronics   Health Care/Hospital 
Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office
2026-03-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
2026-03-12T    Biotechnology   Health Care/Hospital 
LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility
2026-03-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
/C O R R E C T I O N -- Gesynta Pharma/
2026-03-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'
2026-03-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer
2026-03-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bota Launches SAION AI -- Physical AI Platform for Biomanufacturing
2026-03-11T    Biotechnology   Computer/Electronics 
Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
2026-03-10T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.